243 research outputs found

    Linked routine data to enhance health-economics analysis

    Get PDF
    <a href="http://dx.doi.org/10.7175/fe.v14i2.677">http://dx.doi.org/10.7175/fe.v14i2.677</a><br /

    Borassus aethiopum Mart. (Arecaceae) in Limpopo province with a key to South African palms

    Get PDF
    Background: Borassus aethiopum Mart. commonly occurs in many parts of tropical Africa and in South Africa it is restricted to the Leydsdorp region where it is conspicuous along the Selati River. The species is sometimes considered to have been introduced to South Africa due to its disjunct distribution. It has remained poorly studied and little is known about the local populations of this palm. Objectives: This study provides a descriptive treatment and documents the population structure of B. aethiopum in this area, and presents a key to the six indigenous palm species of South Africa. Methods: All accessible populations were surveyed and documented, and eight transects were randomly placed to gather data on size class distributions. B. aethiopum and other indigenous palm species were compared morphologically. Results: The population structure analyses of B. aethiopum revealed a monotonic decline, but the permutation index suggested that the species is prone to recruitment events. This is supported by patches that are dominated by specific height classes. Leaf shape and size, fruit size and geographical distribution were the diagnostic characters most useful to recognize the species of South African indigenous palms. Conclusion: Borassus aethiopum is distinguishable from other South African palms based on stem, leaf and fruit characters. It is considered as indigenous to Granite Lowveld as the palm is part of the natural vegetation and is characterized by a size class distribution reflecting a stable population

    Co-Occurrence and Characteristics of Patients With Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia : Results From a UK National Register

    Get PDF
    The British Society for Rheumatology (BSR) Biologics Register in Ankylosing Spondylitis is funded by the BSR and they have receive funds for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts and can provide comments but have no input into determining the topics for analysis, publication and no input into the work involved in this analysis. This analysis is part-funded by Arthritis Research UK (Grant No: 21378)Peer reviewedPublisher PD

    Responsiveness of serum C‐reactive protein, interleukin‐17A, and interleukin‐17F levels to ustekinumab in psoriatic arthritis: lessons from two phase III, multicenter, double‐blind, placebo‐controlled trials

    Get PDF
    Objective: To evaluate the associations of C‐reactive protein (CRP) and circulating Th17‐associated cytokine levels with psoriatic arthritis (PsA) disease activity and therapeutic response to ustekinumab. Methods: Interleukin‐17A (IL‐17A), IL‐17F, IL‐23, and CRP concentrations were measured in serum samples collected as part of the 2 PSUMMIT phase III studies of ustekinumab in PsA (n = 927). In post hoc analyses, relationships of IL‐17A, IL‐17F, and CRP levels at baseline, week 4, and week 24 with baseline skin and joint disease activity and response to therapy were evaluated using generalized linear models and Pearson's product‐moment correlation tests. Results: Baseline serum levels of IL‐17A and IL‐17F were positively correlated with baseline skin disease scores (r = 0.39–0.62). IL‐23 levels were correlated with skin disease scores to a lesser extent (r = 0.26–0.31). No significant correlations were observed between these cytokine or CRP levels and baseline joint disease activity. There was no significant association of baseline levels of IL‐17A, IL‐17F, IL‐23, or CRP with therapeutic response to ustekinumab in either the skin or joints. Significant reductions from baseline in levels of IL‐17A, IL‐17F, and CRP were seen in patients treated with ustekinumab compared to those treated with placebo. Ustekinumab‐treated patients in whom 75% improvement in the Psoriasis Area and Severity Index score or 20% improvement according to the American College of Rheumatology criteria was achieved after 24 weeks of treatment had greater reductions in CRP level (geometric mean decreases of 51–58% versus 32–33%; P &lt; 0.05), but not IL‐17A or IL‐17F levels, than nonresponders. Conclusion: Baseline serum IL‐23/IL‐17 levels correlated with skin, but not joint, disease activity, suggesting tissue‐specific variation. However, neither baseline Th17‐associated cytokine levels nor CRP level were predictive of therapeutic response to ustekinumab in the skin or joints, despite rapid reductions in their levels following ustekinumab therapy

    The associations between self-reported depression, self-reported chronic inflammatory conditions and cognitive abilities in UK Biobank

    Get PDF
    Background: Depression and chronic inflammatory medical conditions have been linked to impaired cognitive ability. However despite frequent comorbidity, their combined association with cognitive ability has rarely been examined. Methods: This study examined associations between self-reported depression and chronic inflammatory diseases and their interaction with cognitive performance in 456,748 participants of the UK Biobank, adjusting for sociodemographic and lifestyle factors. Numbers with available data ranged from 94,899 to 453,208 depending on the cognitive test. Results: Self-reported depression was associated with poorer performance compared to controls in several cognitive tests (fully adjusted models, reaction time: B = 6.08, 95% CI = 5.09, 7.07; pairs matching: incidence rate ratio = 1.02, 95% CI = 1.02, 1.03; Trail Making Test B: B = 1.37, 95% CI = 0.88, 1.87; Digit Symbol Substitution Test (DSST): B = −0.35, 95% CI = −0.44, −0.27). Self-reported chronic inflammatory conditions were associated with slower reaction time (B = 3.79, 95% CI = 2.81, 4.78) and lower DSST scores (B = −0.21, 95% CI = −0.30, −0.13). No interaction effects were observed. Discussion: In this large, population-based study we provide evidence of lower cognitive performance in both depression and a comprehensive category of chronic inflammatory conditions. Results are consistent with additive effects of both types of disorder on cognitive ability. Clinicians should be aware of such effects, particularly as cognitive impairment is linked to poorer disease outcomes and quality of life

    Level of urbanization and habitat type, and not patch size, influence predacious arthropod diversity patterns of urban grasslands in South Africa

    Get PDF
    Greyvenstein B, Botha M, van den Berg J, Siebert SJ. 2021. Level of urbanization and habitat type, and not patch size, influence predacious arthropod diversity patterns of urban grasslands in South Africa. Biodiversitas 22: 4078-4094. Predacious arthropods provide a valuable ecosystem service within urban environments by suppressing pest numbers. However, urban ecological studies largely ignore this functional group and its diversity and species composition patterns. Some studies have been published regarding these patterns, however they were mostly done in Australia, Europe and America, thus an African perspective is lacking. Our aim was to address the gap in African literature by quantify the differences in predacious arthropod species richness and diversity within urban green space in varying urbanization intensities, habitat types of grassland and patch sizes in South Africa. Various indices were considered to examine the effect of urbanization on the diversity patterns of Chrysopidae (Neuroptera), Mantodea, Araneae and Coccinellidae (Coleoptera). Study sites included three levels of urbanization represented by population density, two types of urban grasslands (i.e., ruderal and fragmented grassland) and a peri-urban rangeland grassland as control, and a wide range of patch sizes. Our results indicated that an increase in urbanization intensities was associated with increased abundance of predacious arthropod taxa. Also, that urban and peri-urban grasslands had similar predacious arthropod species richness and diversity, but differed in species composition. No relationship was found between patch size and arthropod diversity or composition. Thus, predacious arthropod abundances are influenced by the level of urbanization and their species composition is influenced by the type of urban grassland (ruderal or fragmented), which are important considerations for future urban planning/management and conservation strategies. This study gives a South African perspective and indicates that despite the lack of assigned function of urban green spaces, they sustain diverse and distinct predacious arthropod communities, which in turn fulfil various roles in a functioning ecosystem.https://smujo.id/biodivam2022Plant Production and Soil Scienc

    Estimation of input costs for a Markov model in a German health economic evaluation of newer antidepressants

    Get PDF
    Background: Estimating input costs for Markov models in health economic evaluations requires health state-specific costing. This is a challenge in mental illnesses such as depression, as interventions are not clearly related to health states. We present a hybrid approach to health state-specific cost estimation for a German health economic evaluation of antidepressants. Methods: Costs were determined from the perspective of the community of persons insured by statutory health insurance (“SHI insuree perspective”) and included costs for outpatient care, inpatient care, drugs, and psychotherapy. In an additional step, costs for rehabilitation and productivity losses were calculated from the societal perspective. We collected resource use data in a stepwise hierarchical approach using SHI claims data, where available, followed by data from clinical guidelines and expert surveys. Bottom-up and top-down costing approaches were combined. Results: Depending on the drug strategy and health state, the average input costs varied per patient per 8-week Markov cycle. The highest costs occurred for agomelatine in the health state first-line treatment (FT) (“FT relapse”) with €506 from the SHI insuree perspective and €724 from the societal perspective. From both perspectives, the lowest costs (excluding placebo) were €55 for selective serotonin reuptake inhibitors in the health state “FT remission.” Conclusion: To estimate costs in health economic evaluations of treatments for depression, it can be necessary to link different data sources and costing approaches systematically to meet the requirements of the decision-analytic model. As this can increase complexity, the corresponding calculations should be presented transparently. The approach presented could provide useful input for future models

    AxSpA patients who also meet criteria for fibromyalgia:Identifying distinct patient clusters using data from a UK national register (BSRBR-AS)

    Get PDF
    Background: Around 1 in 8 patients with axial spondyloarthritis (axSpA) also meet criteria for fibromyalgia and such patients have considerable unmet need. Identifying effective therapy is important but to what extent fibromyalgia-like symptoms relate to axSpA disease severity has not been established. The aim of the current analysis was to determine whether distinct clusters of axSpA patients exist and if so to determine a) whether they differ in terms of prevalence of fibromyalgia and b) the features of patients in clusters with high prevalence. Methods: The British Society for Rheumatology Biologics Register (BSRBR-AS) recruited axSpA patients from 83 centres 2012-2017. Clinical data, and information from patients was collected (including research criteria for fibromyalgia). Cluster analysis was undertaken using split samples for development and validation both in the whole population and the sub-group which met fibromyalgia criteria. Results: One thousand three hundred thirty-eight participants were included of whom 23% met research criteria for fibromyalgia. Four clusters were identified. Two exhibited very high disease activity, one which was primarily axial (n = 347) and a smaller cluster (n = 32) with axial and peripheral disease, and in both groups more than half of members met criteria for fibromyalgia. The remaining two clusters (n = 437, n = 462) had overall less severe disease however the one which showed greater disease activity and poorer quality of life had a higher proportion meeting fibromyalgia criteria (16% v. 4%). Within those meeting fibromyalgia criteria there were three clusters. The two main groups were defined by level of symptom severity with a smaller third cluster noted to have high average swollen and tender joint counts and high levels of comorbidity. Conclusions: The major feature defining clusters with a high proportion of persons meeting criteria for fibromyalgia is high axSpA disease activity although clusters with features of fibromyalgia in the absence of high disease activity also show moderately high prevalence. Management may be most successful with pharmacologic therapy to target inflammation but enhanced by the concurrent use of non-pharmacologic therapy in such patients

    The information needs of people living with ankylosing spondylitis: a questionnaire survey

    Get PDF
    &lt;p&gt;BACKGROUND:Today, health care is patient-centred with patients more involved in medical decision making and taking an active role in managing their disease. It is important that patients are appropriately informed about their condition and that their health care needs are met. We examine the information utilisation, sources and needs of people with ankylosing spondylitis (AS).&lt;/p&gt; &lt;p&gt;METHODS: Participants in an existing AS cohort study were asked to complete a postal or online questionnaire containing closed and open-ended questions, regarding their information access and needs. Participants were stratified by age and descriptive statistics were performed using STATA 11, while thematic analysis was performed on open-ended question narratives. Qualitative data was handled in Microsoft Access and explored for emerging themes and patterns of experiences.&lt;/p&gt; &lt;p&gt;RESULTS: Despite 73% of respondents having internet access, only 49% used the internet to access information regarding AS. Even then, this was only infrequently. Only 50% of respondents reported accessing written information about AS, which was obtained mainly in specialist clinics. Women were more likely than men to access information (63% (women) 46% (men)) regardless of the source, while younger patients were more likely to use online sources. The main source of non-written information was the rheumatologist. Overall, the respondents felt there was sufficient information available, but there was a perception that the tone was often too negative. The majority (95%) of people would like to receive a regular newsletter about AS, containing positive practical and local information. Suggestions were also made for more information about AS to be made available to non-specialist medical professionals and the general public.&lt;/p&gt; &lt;p&gt;CONCLUSIONS: There appears to be sufficient information available for people with AS in the UK and this is mostly accessed by younger AS patients. Many patients, particularly men, choose not to access AS information and concerns were raised about its negative tone. Patients still rely on written and verbal information from their specialists. Future initiatives should focus on the delivery of more positive information, targeting younger participants in particular and increasing the awareness in the general population and wider non-specialist medical community.&lt;/p&gt
    corecore